Rhythm & Stroke · Note 34
Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion
A New England Journal of Medicine trial tested endovascular therapy for mild stroke caused by large-vessel occlusion, a group often excluded from thrombectomy trials.
Mechanical thrombectomy is firmly established for severe strokes caused by a large blocked vessel. Patients with mild deficits have been treated more cautiously, because their symptoms are modest and the procedure carries risk. But mild stroke can worsen, and a large occlusion is still a large occlusion.
The trial randomised patients with mild stroke and large-vessel occlusion to endovascular therapy plus medical care or medical care alone. It addresses a genuine gap: previous trials enrolled patients with more severe deficits, so clinicians have been extrapolating to a population that was never well studied.
The full paper should be read for the functional outcomes, the rate of symptomatic haemorrhage and the time window studied. A positive result would expand thrombectomy eligibility; a neutral one would support caution in patients who are already functioning reasonably well.
Keep in mind
- The trial compared thrombectomy plus medical care with medical care alone.
- Functional outcome and bleeding risk are the decisive results.
Source and reuse
This is an independent editorial summary written for Heartline. It is not a verbatim reproduction and does not reproduce paywalled text. Reporting, data and quotations belong to NEJM. Read the original at the link provided.
Metadata basis: the publisher’s public RSS feed and the abstract it exposes. Where the full article could not be accessed, this note is explicitly metadata-based and limited to what the feed disclosed. It is not medical advice.
Read the original at NEJM →